[The relationship of coagulation factors to hypoxic newborn infants during therapy with buffer solutions].
D001639:Bicarbonates / Q000627:therapeutic use; D001779:Blood Coagulation Factors / Q000032:analysis*; D005164:Factor IX / Q000032:analysis; D005165:Factor V / Q000032:analysis; D005167:Factor VII / Q000032:analysis; D005170:Factor X / Q000032:analysis; D006801:Humans; D000860:Hypoxia / Q000097:blood*; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000097:blood* / Q000188:drug therapy / Q000401:mortality; D011516:Prothrombin / Q000032:analysis; D012127:Respiratory Distress Syndrome, Newborn / Q000097:blood* / Q000188:drug therapy / Q000401:mortality; D012964:Sodium / Q000627:therapeutic use; D013925:Thromboplastin; D014325:Tromethamine / Q000627:therapeutic use
D001639:Bicarbonates; D001779:Blood Coagulation Factors; D014325:Tromethamine; D005165:Factor V; D005167:Factor VII; D011516:Prothrombin; D005164:Factor IX; D005170:Factor X; D013925:Thromboplastin; D012964:Sodium
Das Verhalten der Gerinnungsfaktoren bei hypoxischen Neugeborenen unter der Puffertherapie.